D-Dimer Detection Reagent(D-Dimer)(Immunofluorescence Chromatography)
D-dimer Overview
D-Dimer (D-dimer) is an important marker of acute thrombosis. Its increase reflects the phenomenon of enhanced coagulation and fibrinolytic activity in vivo. It is not only an index reflecting the existence or continuous formation of thrombus in the body, but also an index reflecting the enhancement of fibrinolytic activity in the body. Among fibrin degradation products, D-dimer can reflect the thrombolytic activity after thrombosis, which is of great value for clinical diagnosis and treatment of thrombotic diseases.
D-dimer Performance Index
| Detection range | sample size | Sample type | Test time |
| 0.1~10mg/L | 60μl | Whole blood / plasma | 5min
|
D-dimer Clinical Significance
- Screening of disseminated intravascular coagulation (DIC)
- Screening of deep venous thrombosis (DVT)
- Screening of pulmonary embolism
- Diagnosis and evaluation of liver diseases and malignant tumors
- Diagnosis of cardiovascular disease
- The application of CT in patients undergoing operation
- Monitoring and evaluation of thrombolytic therapy
| Acute thrombosis in the blood circulation system |
| vein | artery | Microvascular circulation |
| Deep venous thrombosis (DVT) Pulmonary embolism (PE)
Intracranial venous thrombosis (CVT) | Acute coronary syndrome (ACS)
apoplexy | Disseminated intravascular coagulation (DIC) |
Application Department
Laboratory, cardiology, ICU, emergency department, pediatrics, operating room, obstetrics, chest pain center, etc
D-dimer Clinical Comparison
| Outpatients with venous thromboembolism |
| Clinical pre evaluation |
| Low / moderate suspicious | Highly suspicious |
| D-Dimer<0.5mg/L | D-Dimer≧0.5mg/L |
| Thromboembolism was excluded | It is suggested that thromboembolism should be further examined |
| No treatment required | Clinical auxiliary examination |
| | No thromboembolism | Thromboembolism |
| | No treatment required | treatment |
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.
